Tajikistan Receives New Packages of AstraZeneca and Pfizer-BioNTech
Read also
DUSHANBE, 15.11.2021 (NIAT Khovar) – On November 14, Tajikistan received 192,000 doses of the AstraZeneca vaccine and 117,000 doses of the Pfizer-BioNTech vaccine as part of the COVAX mechanism and the program for the fair distribution of the COVID-19 vaccine, reports the Ministry of Health and Social Protection of the Population.
Today, the United States delivered 117,000 out of 198,900 doses of the Pfizer vaccine to Tajikistan for the continued fight against the COVID-19 pandemic through the USAID and the COVAX facility. The remaining 81,900 doses will arrive this week. This latest donation adds to the 325,260 Pfizer doses that were delivered in September, and 1.5 million Moderna doses delivered in July 2021.
Also, this morning, the Republic of Latvia sent 60,000 doses of the AstraZeneca vaccine to Tajikistan as humanitarian aid.
The reception ceremony was attended by representatives of the Ministry of Health and Social Protection of the Population and other officials.
According to the decision of the Republican COVID-19 Prevention Commission, vaccination is mandatory for citizens over 18 years old.
The vaccine is provided to the citizens free of charge.
Tajik Center for Strategic Research and International Institute of Central Asia Discusses Issues of Scientific and Analytical Cooperation
Tajikistan and Iran Plan to Hold a Meeting of Heads of Rescue Departments on Glacier Protection in Dushanbe
Number of Unemployed Citizens Decreases in Tajikistan
Tajik Youth Will Take Part in the India-Central Asia Youth Forum
Tajikistan and Azerbaijan Expand Cooperation in Digitalization of the Labor Market
Tajikistan and Iran Intend to Introduce New Diagnostic and Treatment Methods
Delegation of the Communist Party of China Arrives in Tajikistan
Tajikistan and the U.S. Discuss Healthcare Cooperation
WHO Ready to Expand Cooperation with Tajikistan
